FDG-PET assessment and metabolic patterns in Lafora disease.
Muccioli L, Farolfi A, Pondrelli F, d'Orsi G, Michelucci R, Freri E, Canafoglia L, Licchetta L, Toni F, Bonfiglioli R, Civollani S, Pettinato C, Maietti E, Marotta G, Fanti S, Tinuper P, Bisulli F.
Muccioli L, et al.
Eur J Nucl Med Mol Imaging. 2020 Jun;47(6):1576-1584. doi: 10.1007/s00259-019-04647-3. Epub 2019 Dec 19.
Eur J Nucl Med Mol Imaging. 2020.
PMID: 31858178
PURPOSE: To describe cerebral glucose metabolism pattern as assessed by (18)F-fluorodeoxyglucose positron emission tomography (FDG-PET) in Lafora disease (LD), a rare, lethal form of progressive myoclonus epilepsy caused by biallelic mutations in EPM2A or NHLRC1. .. …
PURPOSE: To describe cerebral glucose metabolism pattern as assessed by (18)F-fluorodeoxyglucose positron emission tomography (FDG-PET) in …